scispace - formally typeset
A

Aroldo Rizzo

Researcher at Queen Mary University of London

Publications -  56
Citations -  2253

Aroldo Rizzo is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Giant cell arteritis & Inflammation. The author has an hindex of 23, co-authored 52 publications receiving 1780 citations.

Papers
More filters
Journal ArticleDOI

Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.

TL;DR: Gut-derived IL-17+ and IL-22+ILC3 are expanded in the peripheral blood, SF and inflamed BM of patients with AS, suggesting the presence of an active homing axis between the gut and the inflamed sacroiliac joints.
Journal ArticleDOI

Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism

TL;DR: CML-derived exosomes promote, through an autocrine mechanism, the proliferation and survival of tumor cells, both in vitro and in vivo, by activating anti-apoptotic pathways, and it is proposed that this mechanism is activated by a ligand-receptor interaction between TGF-β1, found in CML- derived exosome, and the T GF- β1 receptor in C ML cells.
Journal ArticleDOI

Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with Ankylosing Spondylitis and subclinical gut inflammation

TL;DR: The data suggest that HLA-B27 misfolding occurs in the gut of AS patients and is accompanied by activation of autophagy rather than a UPR, which appears to be associated with intestinal modulation of IL-23 in AS.